Azithromycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70436-019

2 FDA label images from Slate Run Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 70436-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of Azithromycin Dihydrate, showing detailed molecular bonds and arrangement of atoms highlighting the macrolide ring and attached functional groups.*
FDA Label Image

T:\spl Documents\azithromycin Injection\spl\label-500mg V3.0 Cropped.jpg (Image 02)

T:\spl Documents\azithromycin Injection\spl\label-500mg V3.0 Cropped.jpg (Image 02)
Azithromycin for Injection, USP 500 mg per vial sterile powder label. Designed for intravenous infusion, it corresponds to 500 mg azithromycin equivalent. The label shows storage instructions, dilution requirements, barcodes, manufacturer (Hainan Poly Pharm, China), and distributor (Slate Run Pharmaceuticals, Columbus, Ohio). Expiration and lot information area is blank for printing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.